Trials / Sponsors / Oraya Therapeutics, Inc.
Oraya Therapeutics, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovasc Age-Related Macular Degeneration, Wet Macular Degeneration, Macular Degeneration | Phase 2 | 2012-09-01 |
| Unknown | Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration Retinal Pigment Epithelial Detachment With Vascularization, Age Related Macular Degeneration | N/A | 2012-08-01 |
| Unknown | IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD Polypoidal Chorodial Vasculopathy, Age Related Macular Degeneration | N/A | 2012-01-01 |
| Withdrawn | Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients Wet Age-related Macular Degeneration, Age-related Macular Degeneration, AMD | N/A | 2011-06-01 |
| Completed | INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD AMD, Wet AMD, Age-Related Macular Degeneration | Phase 2 | 2009-11-01 |
| Unknown | Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Seconda Age-Related Macular Degeneration, Wet Age-Related Macular Degeneration, Macular Degeneration | Phase 1 | 2008-07-01 |